ATE439356T1 - Verfahren zur herstellung von chiralen n-aryl piperazinen - Google Patents

Verfahren zur herstellung von chiralen n-aryl piperazinen

Info

Publication number
ATE439356T1
ATE439356T1 AT03716384T AT03716384T ATE439356T1 AT E439356 T1 ATE439356 T1 AT E439356T1 AT 03716384 T AT03716384 T AT 03716384T AT 03716384 T AT03716384 T AT 03716384T AT E439356 T1 ATE439356 T1 AT E439356T1
Authority
AT
Austria
Prior art keywords
producing chiral
aryl piperazines
piperazines
aryl
chiral
Prior art date
Application number
AT03716384T
Other languages
English (en)
Inventor
Gregg Feigelson
Joseph Zeldis
Ivo Jirkovsky
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE439356T1 publication Critical patent/ATE439356T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
AT03716384T 2002-03-12 2003-03-10 Verfahren zur herstellung von chiralen n-aryl piperazinen ATE439356T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36343102P 2002-03-12 2002-03-12
PCT/US2003/007078 WO2003078417A1 (en) 2002-03-12 2003-03-10 Process for synthesizing chiral n-aryl piperazines

Publications (1)

Publication Number Publication Date
ATE439356T1 true ATE439356T1 (de) 2009-08-15

Family

ID=28041762

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03716384T ATE439356T1 (de) 2002-03-12 2003-03-10 Verfahren zur herstellung von chiralen n-aryl piperazinen

Country Status (23)

Country Link
US (1) US6713626B2 (de)
EP (1) EP1483255B1 (de)
JP (1) JP4391241B2 (de)
KR (1) KR20040105765A (de)
CN (2) CN1982307A (de)
AR (1) AR038930A1 (de)
AT (1) ATE439356T1 (de)
AU (1) AU2003220094B2 (de)
BR (1) BR0308377A (de)
CA (1) CA2477892C (de)
CR (1) CR7431A (de)
DE (1) DE60328756D1 (de)
EC (1) ECSP045290A (de)
ES (1) ES2329122T3 (de)
IL (1) IL163827A0 (de)
MX (1) MXPA04008729A (de)
NO (1) NO20044050L (de)
NZ (1) NZ535168A (de)
RU (1) RU2315762C2 (de)
TW (1) TW200403231A (de)
UA (1) UA79273C2 (de)
WO (1) WO2003078417A1 (de)
ZA (1) ZA200408202B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060287335A1 (en) * 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
US20060223824A1 (en) * 2000-11-28 2006-10-05 Wyeth Serotonergic agents
DK1408976T5 (da) 2001-07-20 2011-01-10 Psychogenics Inc Behandling af ADHD (Attention deficit hyperactivity disorder)
US7361773B2 (en) * 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
US7091349B2 (en) * 2002-03-12 2006-08-15 Wyeth Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
TWI288642B (en) * 2002-03-12 2007-10-21 Wyeth Corp Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
JP2005527530A (ja) * 2002-03-12 2005-09-15 ワイス キラル１，４−二置換ピペラジン
US20070099931A1 (en) * 2004-03-19 2007-05-03 Wyeth Pharmaceutical dosage forms and compositions
US20050209245A1 (en) * 2004-03-19 2005-09-22 Wyeth Process for preparing N-aryl-piperazine derivatives
US20050215561A1 (en) * 2004-03-19 2005-09-29 Krishnendu Ghosh Pharmaceutical dosage forms and compositions
BRPI0609370A2 (pt) * 2005-03-01 2010-03-30 Wyeth Corp cloridrato de 4-ciano-n-{(2r)-2-[4-(2,3-dihidro-benzo[1,4]dioxin-5-il)-pip erazin-1-il]-propil}-n-piridin-2-il-benzamida cristalino e amorfo
CN117003693B (zh) * 2022-05-05 2026-01-30 四川大学华西医院 一类哌啶衍生物及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3586794T2 (de) 1984-12-21 1993-05-27 Duphar Int Res Arzneimittel mit psychotroper wirkung.
JPH01125357A (ja) 1987-11-06 1989-05-17 Dainippon Pharmaceut Co Ltd トリペプチドの誘導体
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives
GB9125900D0 (en) * 1991-12-05 1992-02-05 Wyeth John & Brother Ltd Piperazine derivatives
WO1994024115A1 (fr) * 1993-04-16 1994-10-27 Santen Pharmaceutical Co., Ltd. Nouveau derive de piperazine
GB9411099D0 (en) * 1994-06-03 1994-07-27 Wyeth John & Brother Ltd Piperazine derivatives
DK0763024T3 (da) 1994-06-03 2002-12-02 Wyeth John & Brother Ltd Fremgangmåde og mellemprodukter til fremstilling af piperazinderivater
GB9413772D0 (en) * 1994-07-08 1994-08-24 Wyeth John & Brother Ltd 5-HT1A ligands
GB9514901D0 (en) * 1995-07-20 1995-09-20 American Home Prod Piperazine derivatives
WO1997037655A1 (en) 1996-04-10 1997-10-16 Merck & Co., Inc. αvβ3 ANTAGONISTS
US6469007B2 (en) 2000-11-28 2002-10-22 Wyeth Serotonergic agents

Also Published As

Publication number Publication date
TW200403231A (en) 2004-03-01
NZ535168A (en) 2006-03-31
CN1982307A (zh) 2007-06-20
BR0308377A (pt) 2005-01-11
IL163827A0 (en) 2005-12-18
RU2004130300A (ru) 2005-04-10
NO20044050L (no) 2004-09-24
UA79273C2 (en) 2007-06-11
AU2003220094A1 (en) 2003-09-29
JP4391241B2 (ja) 2009-12-24
EP1483255A1 (de) 2004-12-08
US20030187265A1 (en) 2003-10-02
AR038930A1 (es) 2005-02-02
KR20040105765A (ko) 2004-12-16
ECSP045290A (es) 2004-10-26
CA2477892A1 (en) 2003-09-25
RU2315762C2 (ru) 2008-01-27
EP1483255B1 (de) 2009-08-12
ZA200408202B (en) 2007-03-28
US6713626B2 (en) 2004-03-30
JP2005526775A (ja) 2005-09-08
CR7431A (es) 2008-07-29
ES2329122T3 (es) 2009-11-23
DE60328756D1 (de) 2009-09-24
MXPA04008729A (es) 2005-07-13
CN1304388C (zh) 2007-03-14
CA2477892C (en) 2010-11-23
AU2003220094B2 (en) 2009-04-23
CN1642936A (zh) 2005-07-20
WO2003078417A1 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
ATE340819T1 (de) Verfahren zur herstellung von polyamiden
DE60221399D1 (de) Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de) Verfahren zur herstellung von o- desmethylvenlafaxin
ATE353322T1 (de) Verfahren zur herstellung von 2- (chinoxalin-5- ylsulfonylamino) -benzamid-verbindungen
ATA11912002A (de) Verfahren zur herstellung von fälschungssicheren identifikationsmerkmalen
DE60230908D1 (de) Verfahren zur herstellung von polyarylenethern
DE60327788D1 (de) Verfahren zur herstellung von polytrimethylenterephthalt-fasern
ATE308524T1 (de) Verfahren zur herstellung von aripiprazole
DE50308650D1 (de) Verfahren zur herstellung von cellulosecarbamatformkörpern
ATE448209T1 (de) Verfahren zur herstellung von pyrimidinverbindungen
ATE439356T1 (de) Verfahren zur herstellung von chiralen n-aryl piperazinen
DE602004022134D1 (de) Verfahren zur herstellung von dinitrilen
ATE456569T1 (de) Verfahren zur herstellung von 6-alkyliden- penemderivaten
ATE296287T1 (de) Verfahren zur herstellung von repaglinide
ATE553103T1 (de) Verfahren zur herstellung von (s)-pantoprazol
ATE432918T1 (de) Verfahren zur herstellung von cpla 2-inhibitoren
ATE453619T1 (de) Verfahren zur herstellung von hydroperoxiden
DE50303611D1 (de) Verfahren zur herstellung von polyisobuten
ATE336478T1 (de) Verfahren zur herstellung von benzophenonen
DE502004004318D1 (de) Verfahren zur herstellung von metall-matrix-verbundwerkstoffen
DE50200870D1 (de) Verfahren zur herstellung von hydroxyalkylpolysiloxanen
ATE402138T1 (de) Verfahren zur herstellung von 2- aminoindanderivaten
ATE371642T1 (de) Verfahren zur herstellung von 3- methylthiopropanal
ATE471941T1 (de) Verfahren zur herstellung von thiazolopyrimidinen
ATE382621T1 (de) Verfahren zur herstellung von nevirapin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties